Literature DB >> 12774937

Supramolecular assemblies of DNA delivery systems.

Bruno Pitard1.   

Abstract

Gene delivery into cultured cells or in vivo is a promising approach to the treatment of diseases. Several gene delivery systems have been developed to promote gene expression either in vitro or in vivo. Concerns about viral-induced immune responses, the risk associated with replication-competent viruses, and production issues have stimulated efforts toward the development of alternative gene delivery systems such as cationic lipids and polymers. These positively charged molecules interact through electrostatic forces with DNA. This results in the formation of highly organized supramolecular structures where DNA molecules are condensed and protected against DNAses degradation. Association of DNA with cationic lipids under a micellar or liposomal form leads to lamellar organization with DNA molecules sandwiched between lipid bilayers. Although the lamellar phase is the common described structure, as evidenced by small-angle X-ray scattering and electron microscopy, monovalent cationic lipid combined with a hexagonal forming lipid resulted with DNA in an inverted hexagonal structure. Despite a lot of effort, the mechanism of gene transfer with cationic carrier is still ill-defined. Therefore, correlations need to be established between physicochemical properties of synthetic DNA delivery systems and in vitro and in vivo transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12774937     DOI: 10.1023/a:1022923721335

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  9 in total

Review 1.  Nature as a source of inspiration for cationic lipid synthesis.

Authors:  Romain Labas; Fanny Beilvert; Benoit Barteau; Stéphanie David; Raphaël Chèvre; Bruno Pitard
Journal:  Genetica       Date:  2009-09-11       Impact factor: 1.082

2.  Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference.

Authors:  Léa Desigaux; Matthieu Sainlos; Olivier Lambert; Raphael Chevre; Emilie Letrou-Bonneval; Jean-Pierre Vigneron; Pierre Lehn; Jean-Marie Lehn; Bruno Pitard
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-08       Impact factor: 11.205

Review 3.  Novel tumour antigens and the development of optimal vaccine design.

Authors:  Victoria A Brentville; Suha Atabani; Katherine Cook; Lindy G Durrant
Journal:  Ther Adv Vaccines Immunother       Date:  2018-04-10

4.  Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer.

Authors:  Bruno Pitard; Mahajoub Bello-Roufaï; Olivier Lambert; Peggy Richard; Léa Desigaux; Sarah Fernandes; Caroline Lanctin; Hélène Pollard; Mehdi Zeghal; Pierre-Yves Rescan; Denis Escande
Journal:  Nucleic Acids Res       Date:  2004-11-16       Impact factor: 16.971

5.  DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy mice.

Authors:  Stephanie David; Catherine Passirani; Nathalie Carmoy; Marie Morille; Mathieu Mevel; Benoit Chatin; Jean-Pierre Benoit; Tristan Montier; Bruno Pitard
Journal:  Mol Ther Nucleic Acids       Date:  2013-01-08       Impact factor: 10.183

6.  Relationships between the physicochemical properties of an amphiphilic triblock copolymers/DNA complexes and their intramuscular transfection efficiency.

Authors:  Mahajoub Bello-Roufaï; Olivier Lambert; Bruno Pitard
Journal:  Nucleic Acids Res       Date:  2006-12-20       Impact factor: 16.971

Review 7.  Current Strategies to Enhance Anti-Tumour Immunity.

Authors:  Katherine W Cook; Lindy G Durrant; Victoria A Brentville
Journal:  Biomedicines       Date:  2018-03-23

Review 8.  mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.

Authors:  Zhuoya Deng; Yuying Tian; Jianxun Song; Guangwen An; Penghui Yang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

9.  Dendrimer-Coated Gold Nanoparticles for Efficient Folate-Targeted mRNA Delivery In Vitro.

Authors:  Londiwe Simphiwe Mbatha; Fiona Maiyo; Aliscia Daniels; Moganavelli Singh
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.